Literature DB >> 20415855

99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: the normal gut microbiota in health and disease.

F Bäckhed1.   

Abstract

Mammals are metagenomic, in that they are composed not only of their own genome but also those of all of their associated microbes (microbiome). Individual variations in the microbiome influence host health and may be implicated in disease aetiology. Therefore, it is not surprising that decreased microbial diversity is associated with both obesity and inflammatory bowel disease. Studies in germ-free mice have demonstrated that the gut microbiota is required for development of diet-induced obesity as well as inflammatory diseases. However, the underlying molecular mechanism(s) for how the gut microbiota causes metabolic diseases is only beginning to be clarified. Furthermore, emerging data suggest that the gut microbiota may predispose or protect against other important diseases such as cardiovascular disease and diabetes.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20415855      PMCID: PMC2841839          DOI: 10.1111/j.1365-2249.2010.04123.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  47 in total

1.  A genomic view of the human-Bacteroides thetaiotaomicron symbiosis.

Authors:  Jian Xu; Magnus K Bjursell; Jason Himrod; Su Deng; Lynn K Carmichael; Herbert C Chiang; Lora V Hooper; Jeffrey I Gordon
Journal:  Science       Date:  2003-03-28       Impact factor: 47.728

2.  Insulin signalling and the regulation of glucose and lipid metabolism.

Authors:  A R Saltiel; C R Kahn
Journal:  Nature       Date:  2001-12-13       Impact factor: 49.962

3.  Toll-like receptor 4 polymorphisms and atherogenesis.

Authors:  Stefan Kiechl; Eva Lorenz; Markus Reindl; Christian J Wiedermann; Friedrich Oberhollenzer; Enzo Bonora; Johann Willeit; David A Schwartz
Journal:  N Engl J Med       Date:  2002-07-18       Impact factor: 91.245

4.  The contribution of the large intestine to energy supplies in man.

Authors:  N I McNeil
Journal:  Am J Clin Nutr       Date:  1984-02       Impact factor: 7.045

5.  Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E.

Authors:  Kathrin S Michelsen; Michelle H Wong; Prediman K Shah; Wenxuan Zhang; Juliana Yano; Terence M Doherty; Shizuo Akira; Tripathi B Rajavashisth; Moshe Arditi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

6.  A genetic basis for the "Adonis" phenotype of low adiposity and strong bones.

Authors:  Geoffrey B Johnson; B Lawrence Riggs; Jeffrey L Platt
Journal:  FASEB J       Date:  2004-06-18       Impact factor: 5.191

7.  Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki Heart Study.

Authors:  P Saikku; M Leinonen; L Tenkanen; E Linnanmäki; M R Ekman; V Manninen; M Mänttäri; M H Frick; J K Huttunen
Journal:  Ann Intern Med       Date:  1992-02-15       Impact factor: 25.391

8.  Honor thy symbionts.

Authors:  Jian Xu; Jeffrey I Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-08-15       Impact factor: 11.205

9.  Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways.

Authors:  Harry Björkbacka; Vidya V Kunjathoor; Kathryn J Moore; Stephanie Koehn; Christine M Ordija; Melinda A Lee; Terry Means; Kristen Halmen; Andrew D Luster; Douglas T Golenbock; Mason W Freeman
Journal:  Nat Med       Date:  2004-03-14       Impact factor: 53.440

10.  Infectious agents are not necessary for murine atherogenesis.

Authors:  S D Wright; C Burton; M Hernandez; H Hassing; J Montenegro; S Mundt; S Patel; D J Card; A Hermanowski-Vosatka; J D Bergstrom; C P Sparrow; P A Detmers; Y S Chao
Journal:  J Exp Med       Date:  2000-04-17       Impact factor: 14.307

View more
  18 in total

Review 1.  The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.

Authors:  Helena Tlaskalová-Hogenová; Renata Stěpánková; Hana Kozáková; Tomáš Hudcovic; Luca Vannucci; Ludmila Tučková; Pavel Rossmann; Tomáš Hrnčíř; Miloslav Kverka; Zuzana Zákostelská; Klára Klimešová; Jaroslava Přibylová; Jiřina Bártová; Daniel Sanchez; Petra Fundová; Dana Borovská; Dagmar Srůtková; Zdeněk Zídek; Martin Schwarzer; Pavel Drastich; David P Funda
Journal:  Cell Mol Immunol       Date:  2011-01-31       Impact factor: 11.530

Review 2.  Opportunities and Challenges for Environmental Exposure Assessment in Population-Based Studies.

Authors:  Chirag J Patel; Jacqueline Kerr; Duncan C Thomas; Bhramar Mukherjee; Beate Ritz; Nilanjan Chatterjee; Marta Jankowska; Juliette Madan; Margaret R Karagas; Kimberly A McAllister; Leah E Mechanic; M Daniele Fallin; Christine Ladd-Acosta; Ian A Blair; Susan L Teitelbaum; Christopher I Amos
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-07-14       Impact factor: 4.254

3.  Associations between Gut Microbial Colonization in Early Life and Respiratory Outcomes in Cystic Fibrosis.

Authors:  Anne G Hoen; Jing Li; Lisa A Moulton; George A O'Toole; Molly L Housman; Devin C Koestler; Margaret F Guill; Jason H Moore; Patricia L Hibberd; Hilary G Morrison; Mitchell L Sogin; Margaret R Karagas; Juliette C Madan
Journal:  J Pediatr       Date:  2015-03-26       Impact factor: 4.406

4.  Broadening the translational immunology landscape.

Authors:  M Peakman
Journal:  Clin Exp Immunol       Date:  2012-12       Impact factor: 4.330

5.  The risk of addressing only risks.

Authors:  Garry Egger; John Dixon
Journal:  CMAJ       Date:  2014-05-20       Impact factor: 8.262

6.  99th Dahlem conference on infection, inflammation and chronic inflammatory disorders: lifestyle changes affecting the host-environment interface.

Authors:  S Ehlers; S H E Kaufmann
Journal:  Clin Exp Immunol       Date:  2010-04       Impact factor: 4.330

Review 7.  Neonatal Gastrointestinal and Respiratory Microbiome in Cystic Fibrosis: Potential Interactions and Implications for Systemic Health.

Authors:  Juliette C Madan
Journal:  Clin Ther       Date:  2016-03-10       Impact factor: 3.393

Review 8.  Normal neonatal microbiome variation in relation to environmental factors, infection and allergy.

Authors:  Juliette C Madan; Shohreh F Farzan; Patricia L Hibberd; Margaret R Karagas
Journal:  Curr Opin Pediatr       Date:  2012-12       Impact factor: 2.856

9.  Gut microbial colonisation in premature neonates predicts neonatal sepsis.

Authors:  Juliette C Madan; Richard Cowper Salari; Deepti Saxena; Lisa Davidson; George A O'Toole; Jason H Moore; Mitchell L Sogin; James A Foster; William H Edwards; Paul Palumbo; Patricia L Hibberd
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2012-05-06       Impact factor: 5.747

10.  In search of a germ theory equivalent for chronic disease.

Authors:  Garry Egger
Journal:  Prev Chronic Dis       Date:  2012-05-10       Impact factor: 2.830

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.